September 26, 2026

Global Deep Dives

How to Value Bitcoin: Realized Cap, MVRV, HODL Waves and the Cost-Basis Map Behind BTC

Bitcoin has no earnings, cash flow or book value, so traditional valuation ratios fail. This guide explains realized cap, MVRV, HODL waves, cost basis and how to use on-chain valuation.

Mehr lesen

Bitcoin Spot ETF Flows Explained: What $61 Billion in IBIT Assets Actually Means for BTC Price

Bitcoin ETFs have changed who can own BTC, but ETF inflows do not translate one-for-one into price. This guide explains IBIT, creations, redemptions, custody, fees, flows and the market-structure traps.

Mehr lesen

SiriusXM Stock After Q2 2026: The Cash Flow Is Real — but Is $9.5 Billion of Debt Still Too Much?

SiriusXM raised guidance after Q2 as free cash flow jumped 48% and churn hit a record low. I test whether the stock is genuinely cheap or still a leveraged value.

Mehr lesen

Apple M6 & John Ternus: 2nm AI Silicon, Buybacks & Valuation

Apple enters a new CEO era just days after launching its first 2nm M6 chip. I examine why custom silicon, on-device AI and a $4.7 trillion valuation make the next.

Mehr lesen

American Eagle Stock 2026: Aerie +19%, Tariff Refund & Valuation

American Eagle Outfitters looks like an old-line apparel retailer until you separate the brands. Aerie now earns more than twice American Eagle's segment profit on less revenue — just as.

Mehr lesen

Applied Digital Stock 2026: $36B Leases, Rent Timing & Valuation

Applied Digital’s FY2026 numbers finally put real revenue behind the AI data-center story. But fit-out revenue, base rent, NOI, debt and live capacity tell very different stories.

Mehr lesen

Relative Volume (RVOL): Formula, Scanner, Strategy & Examples

Relative Volume helps separate ordinary price movement from unusual participation. This guide explains RVOL, RVOL at Time, scanners, breakouts, false signals and practical trade filters.

Mehr lesen

VWAP Trading Strategy: Formula, Entries, Reclaims & Mean Reversion

VWAP is more than a line on a chart. This guide explains the formula, why institutions benchmark against it, how traders use reclaims and mean reversion, and where VWAP signals.

Mehr lesen

Moderna Stock 2026: Phase 3 Cancer Vaccine Wins — Is the MRNA Rally Already Too Far?

Moderna’s Phase 3 melanoma trial with Merck met its primary and key secondary endpoints. MRNA now has real oncology proof, but Q2 revenue was only $0.1B and cash burn remains.

Mehr lesen

Nebius Stock 2026: AI Cloud Growth, $5.75B Debt & Valuation

Nebius stock has become one of the market’s hottest AI infrastructure trades. Revenue is exploding and capacity is sold out, but $5.75 billion of new convertible debt changes the risk..

Mehr lesen